Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...
Skin issues like dryness, itching, dark patches (acanthosis nigricans), fungal infections & slow-healing wounds can be early ...
Those gray hairs could actually have a serious silver lining—they could be a sign that your body is working to avoid a type ...